Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Bio Simulation Technology Global Market, By Product & Data Validation, Analysis and Forecast 2022

Thursday, December 1, 2016 8:58
% of readers think this story is Fact. Add your two cents.

(Before It's News)

According to Publisher, the Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the biologics and biosimilars markets, increased use of personalized medicines, technological advancements and periodic product upgradation are the key factors vitalizing the market growth. However, lack of standardization, high R&D costs associated with development of biosimulation software and lack of skilled professionals are some of the major restraints hampering the market growth. Industrial bioprocessing, nutraceuticals, agri-food production and biosimulation in the defense will provide opportunities for market growth over the forecast period.

 

For more information about this report: http://www.reportsweb.com/bio-simulation-technology-global-market-outlook-2015-2022

                                                                                                                         

Pharmaceutical and biotechnology companies segment is valued to account largest share across the global market. North America is anticipated to command the largest share and Europe is expected to register the highest growth due to increasing government funding and the large number of pharmaceuticals and biotechnology companies in this region.

Some of the key players in this market include Certara USA Inc., Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC, Rhenovia Pharma Ltd., Insilico biosciences, Archimedes, Insilico biotechnology, Accelrys, LeadScope and Compugen.

Application Covered:
- Application In Drug Development
- Clinical Trials
- Preclinical Testing
- In Patient Validation
- Application In Drug Discovery
- Target Validation
- Target Identification
- Lead Identification/Discovery
- Lead Optimization

Product Covered:
- Software 
- Toxicity Prediction Software
- Molecular Modeling and Simulation Software
- Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Other Software
- Services
- External/Contract Services
- In-House Services

End user Covered:
- Regulatory Authorities
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations 
 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001216406/sample

 

Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK 
- Spain 
- Rest of Europe 
- Asia Pacific
- Japan 
- China 
- India 
- Australia 
- New Zealand 
- Rest of Asia Pacific 
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

 

Company Profiling 
10.1 Certara USA, Inc. 
10.2 Simulation Plus Inc. 
10.3 Dassault Systèmes SA 
10.4 Schrödinger Inc. 
10.5 Advanced Chemistry Development, Inc. 
10.6 Chemical Computing Group, Inc. 
10.7 Entelos Holding Corporation 
10.8 Genedata Ag 
10.9 Physiomics PLC 
10.10 Rhenovia Pharma Ltd. 
10.11 Insilico biosciences 
10.12 Archimedes 
10.13 Insilico biotechnology 
10.14 Accelrys 
10.15 LeadScope 
10.16 Compugen 

 

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001216406/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.